TPI Fund Managers’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$26.7M Sell
55,425
-11,183
-17% -$5.53M 4.48% 6
2022
Q1
$32.7M Buy
66,608
+3,195
+5% +$1.46M 4.21% 6
2021
Q4
$29.4M Buy
+63,413
New +$26.7M 3.62% 7
2021
Q3
Sell
-58,857
Closed -$22.5M 41
2021
Q2
$22.5M Buy
58,857
+457
+0.8% +$175K 3.1% 11
2021
Q1
$21M Buy
58,400
+12,800
+28% +$4.12M 3.28% 12
2020
Q4
$14.6M Buy
45,600
+7,074
+18% +$2.17M 2.5% 17
2020
Q3
$10.3M Sell
38,526
-16,126
-30% -$4.34M 2.21% 19
2020
Q2
$14.4M Buy
54,652
+17,045
+45% +$4.55M 3.33% 11
2020
Q1
$8.54M Buy
37,607
+2,031
+6% +$553K 2.59% 16
2019
Q4
$10.7M Buy
35,576
+2,917
+9% +$803K 2.59% 16
2019
Q3
$7.84M Buy
32,659
+1,468
+5% +$402K 2.23% 19
2019
Q2
$8.8M Buy
+31,191
New +$8.52M 2.69% 17

Other funds holding ELV

TPI Fund Managers's ELV Position: Q2 2022 in Review

TPI Fund Managers reduced its Elevance Health (ELV) stake by 17% in Q2 2022, selling an estimated $5.53M and leaving 55,425 shares worth $26.7M. The position accounts for 4.48% of the portfolio, ranked #6.

TPI Fund Managers first reported a position in ELV in Q2 2019 and has held it in 12 quarters since. The position peaked at $32.7M in Q1 2022. 1,439 funds tracked by Wall St. Rank hold ELV as of Q2 2022.

  • TPI Fund Managers held 55,425 shares of Elevance Health worth $26.7M as of Q2 2022.
  • TPI Fund Managers sold 11,183 Elevance Health shares in Q2 2022, an estimated $5.53M.
  • Elevance Health made up 4.48% of TPI Fund Managers's portfolio in Q2 2022, its #6 holding.
  • TPI Fund Managers first reported a position in Elevance Health in Q2 2019 and has held it in 12 quarters since.
  • TPI Fund Managers's Elevance Health position peaked at $32.7M in Q1 2022.
  • 1,439 funds tracked by Wall St. Rank held Elevance Health as of Q2 2022.

Based on TPI Fund Managers's 13F filing for Q2 2022, filed 8 Aug 2022.